Asymptomatic cardiovascular manifestations in diabetes mellitus: left ventricular diastolic dysfunction and silent

Jelena P Seferović-Mitrović1, Nebojsa M Lalić, Bosiljka Vujisić-Tesić

  • 1Department of Endocrinology, Diabetes, and Metabolic Disorders, Clinical Centre of Serbia, Belgrade, Serbia. jpseferovic@yahoo.com

Insights

This study found that 17.3% of type 2 diabetes patients have asymptomatic cardiovascular complications like left ventricular diastolic dysfunction (LVDD) and silent myocardial ischemia (SMI). Early detection is key for managing diabetes-related heart issues.

Area of Science:

  • Cardiology
  • Diabetology
  • Internal Medicine

Background:

  • Cardiovascular complications in diabetes can be asymptomatic.
  • Left ventricular diastolic dysfunction (LVDD) is an early metabolic lesion in diabetic patients, detectable by tissue Doppler echocardiography.
  • Silent myocardial ischemia (SMI) is a common ischemic heart disease manifestation in diabetes.

Purpose of the Study:

  • To determine the prevalence of LVDD and SMI in type 2 diabetes patients.
  • To compare demographic, clinical, and metabolic data between patients with and without LVDD and SMI.

Main Methods:

  • Investigated 104 type 2 diabetic patients with varying blood pressure levels.
  • Conducted laboratory assessments, transthoracic echocardiography with tissue Doppler, and exercise stress echocardiography.

Main Results:

  • LVDD was diagnosed in 11.5% and SMI in 5.8% of patients.
  • Patients with LVDD used metformin less frequently compared to other groups.
  • Higher HDL cholesterol and apolipoprotein A1 levels were observed in patients with LVDD.

Conclusions:

  • The study identified asymptomatic cardiovascular complications in 17.3% of type 2 diabetes patients.
  • Highlights the importance of screening for cardiac abnormalities in diabetic individuals.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...